An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
Jieling ChenMagaly Perez-NievesCarolina Piras De OliveiraErik SpaepenBeatrice OsumiliJiat-Ling PoonNanette SchlootNuria LaraLaura Garcia AlvarezMontserrat RosetPublished in: Postgraduate medicine (2020)
Physicians considered IL200 a promising treatment option that reduces the injection burden for patients on MTI. Physicians adopted a patient-centered perspective by aligning IL200 prescribing decisions with each patient's medical needs and non-clinical preferences, with an aim to encourage treatment adherence through resorting to IL200's advantageous attributes.